How Melanocortin Receptor Agonists Work

Both Melanotan 1 and Melanotan 2 act through the same broad mechanism: binding to melanocortin receptors on the cell surface and triggering a cascade of intracellular signalling. Understanding this pathway is central to interpreting any in vitro result involving these compounds.

The Signalling Cascade

Receptor binding activates adenylyl cyclase via Gs proteins, raising intracellular cyclic AMP (cAMP). Elevated cAMP activates the CREB transcription factor, which upregulates MITF and tyrosinase — the enzyme that catalyses the rate-limiting step of melanin synthesis. In melanocyte cell cultures, this produces a measurable, dose-dependent increase in melanin production, which is one of the most common in vitro readouts used in melanocortin research.

Beyond Pigmentation

Because MC1R and MC3R activation also suppresses NF-κB signalling and downstream inflammatory mediators like TNF-α and IL-6, melanocortin agonists are additionally used as research tools in inflammation models — for example in macrophage and keratinocyte cell lines. MC4R engagement (relevant mainly to Melanotan 2, given its broader receptor profile) has separately made these peptides useful in experimental models of appetite and energy-balance signalling.

For full technical specifications — sequences, molecular formulas, and a research timeline — see the Science page. For how Melanotan 1 and 2 differ structurally, read our compound comparison.